- Stocks Telegraph Morning
- Posts
- 19 Oct - ST - Morning Newsletter (with survey at top and bottom)
19 Oct - ST - Morning Newsletter (with survey at top and bottom)
Today's Top-4 Break Out Stocks
The Newsheater daily morning newsletter is powered by Stocks Telegraph
Help us improve newsletter by taking
Good Morning!Following Netflix's strong earnings, Nasdaq futures surged Tuesday evening as the major averages gained for the two consecutive days.Nasdaq 100 futures rose 1.19%, or 133.75 points. S&P 500 futures rose 0.8% and Dow Jones Industrial Average futures jumped 165 points, or 0.54%.Market uncertainty was eased by earnings reports, as all three major stock averages finished higher. There was an increase of 337 points in the Dow, a gain of 1.1% in the S&P 500, and a rise of 0.9% in the tech-heavy Nasdaq Composite.The extended trading moves followed Netflix's third quarter report of strong subscriber growth and earnings that exceeded estimates. Extended trading saw shares surge as much as 14%.Next week will be a busy one for the tech giants earnings, but IBM and Tesla will post their results today. A report from Snap will be released later this week.
Lithium Triangle a "Treasure Trove" for the Popular Energy Metal
Lithium is the most precious commodity of the green revolution, and experts predict an exploding demand for the energy metal. Surrounded by multi-billion dollar assets, one little-known small-cap company in a renowned location in South America may become a strong link in the lithium supply chain due to a monster acquisition.
Today Top Movers
Netflix Inc. (NFLX) stock soared 13.26% to $272.81 in the pre-market trading after releasing 3rd quarter 2022 financial results.
Intuitive Surgical Inc. (NASDAQ: ISRG) shares are trading up 10.0% at $213.1 at the time of writing following the declaration of third quarter earnings.
Ayala Pharmaceuticals Inc. (AYLA) grew over 15.19% at $1.05 in pre-market trading today after announcing merger agreement with Advaxis, Inc. (ADXS).
NovaBay Pharmaceuticals, Inc. (NBY) gained about 4.76% at $0.1100 in pre-market trading Wednesday. NBY recently announced that its management will present a company overview at the LD Micro Main Event XV on Wednesday, October 26 at 8:00 a.m. Pacific time.
Free Report: Top Stocks to Consider Heading Into the 2022 Midterms
With midterm elections around the corner, the only certainty is uncertainty.
And while we can't say which party is the likely winner, we can point you in the direction of several stocks that could blast higher once the smoke clears.
Top Upgrades & Downgrades
Morgan Stanley turned bullish on Continental Resources Inc. (CLR), upgrading the stock to "Equal-Weight" and assigning a $74 price target, representing potential upside of 0.41% from Tuesday's close.
Netflix Inc. (NFLX) has won the favor of JP Morgan's equity research team. The firm upgraded the shares from Neutral to Overweight and moved their price target to $330, suggesting 37.01% additional upside for the stock.
Lockheed Martin Corporation (LMT) received an upgrade from analysts at Baird, who also set their one-year price target on the stock to $513. They changed their rating on LMT to Outperform from Neutral in a recently issued research note.
Earlier Wednesday Morgan Stanley reduced its rating on Pioneer Natural Resources Company (PXD) stock to Underweight from Equal-Weight and assigned the price target to $261.
Baird analysts reduced their investment ratings, saying in research reports covered by the media that its rating for AVEO Pharmaceuticals Inc. (AVEO) has been changed to Neutral from Outperform and the new price target is set at $15.
Analysts at Piper Sandler downgraded Akouos Inc. (AKUS)'s stock to Neutral from Overweight Wednesday.
6 Stocks Under 5 Bucks
Getting stocks under $5 a share is pretty sweet... But how do you know which stocks will be the big movers? These six low-priced stocks could deliver for investors in a big way.
Latest Insider Activity
Canoo Inc. (GOEV) SVP, ICFO and CAO MURTHY RAMESH announced the sale of shares taking place on Oct 17 at $1.38 for some 972 shares. The total came to more than $1341.0.
ACADIA Pharmaceuticals Inc. (ACAD) President Stankovic Srdjan R. sold on Oct 15 a total 1,326 shares at $15.81 on average. The insider’s sale generated proceeds of almost $20964.0.
Cabaletta Bio Inc. (CABA) Director Simon Mark declared the purchase of shares taking place on Oct 18 at $0.98 for some 7,000 shares. The transaction amount was around $6835.0.
Ares Management Corporation (ARES) 10% Owner ARES MANAGEMENT LLC bought on Oct 14 a total 200,000 shares at $1.47 on average. The purchase cost the insider an estimated $294,920.
Rare Metal Discovery: Tiny Sub-$0.25 Stock Set to Deliver Gains
Smart investors are blowing away Wall Street's so-called experts on clean energy stocks. And with the green-energy revolution in full-swing, the near-term gains could be absolutely life-changing. The timing is dead-on accurate with this sub-US$0.25 stock securing an ultra-rare clean energy resource on North American soil that China doesn't want us to have.
Important Earnings
Top US earnings releases scheduled for today include Ally Financial Inc. (NYSE: ALLY). It will announce its Sep 2022 financial results. The company is expected to report earnings of $1.7 per share from revenues of $2.16B in the three-month period.
Analysts expect Abbott Laboratories (NYSE: ABT) to report a net income (adjusted) of $0.94 per share, when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Sep 2022 is predicted to come in at $9.68B.
Tesla Inc. (TSLA), due to announce earnings after the market closes today, is expected to report earnings of $1 per share from revenues of $21.96B recently concluded three-month period.
That's it for today. Thanks for reading. Good luck out there!Best Regards,Stocks Telegraph Team
P.S. Want my daily watchlists sent to your cell phone too? Just go HERE and join my text message list!
Wouldn’t it be great to have a personalized solution for your investing needs? We’re adding new sections to the morning newsletter with big implications. All you have to do is share your thought about the current newsletter. If you do that, we’ll do our best to take your feedback and make it a better experience for you.
We are asking for 1 minute of your time to answer 4 questions about your experience with our newsletter. We hope to use this information to create solutions that address exactly what you need!
Thank you for your continued support.
Disclaimer: Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails.